申请人:Martin R. Billy
公开号:US20060183922A1
公开(公告)日:2006-08-17
Cannabinoid derivatives that exhibit specificity for the CB
2
cannabinoid receptor are provided. The analogues are tetrahydrocannabinols and hydroxyhexahydrocannabinols, and are useful for the treatment of pain, inflammation, and cancer.
提供了具有对CB2
大麻素受体特异性的
大麻素衍
生物。这些类似物是
四氢大麻酚和羟基六氢
大麻酚,可用于治疗疼痛、炎症和癌症。